731 related articles for article (PubMed ID: 10978167)
1. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
2. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
3. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.
Altrogge LM; Monard D
Anal Biochem; 2000 Jan; 277(1):33-45. PubMed ID: 10610687
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G.
Molino M; Blanchard N; Belmonte E; Tarver AP; Abrams C; Hoxie JA; Cerletti C; Brass LF
J Biol Chem; 1995 May; 270(19):11168-75. PubMed ID: 7744748
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor.
Renesto P; Si-Tahar M; Moniatte M; Balloy V; Van Dorsselaer A; Pidard D; Chignard M
Blood; 1997 Mar; 89(6):1944-53. PubMed ID: 9058715
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
[TBL] [Abstract][Full Text] [Related]
8. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
Miike S; McWilliam AS; Kita H
J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
[TBL] [Abstract][Full Text] [Related]
9. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
Hammes SR; Coughlin SR
Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
[TBL] [Abstract][Full Text] [Related]
10. Thrombin cleaves and activates the protease-activated receptor 2 dependent on thrombomodulin co-receptor availability.
Heuberger DM; Franchini AG; Madon J; Schuepbach RA
Thromb Res; 2019 May; 177():91-101. PubMed ID: 30861432
[TBL] [Abstract][Full Text] [Related]
11. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.
O'Brien PJ; Prevost N; Molino M; Hollinger MK; Woolkalis MJ; Woulfe DS; Brass LF
J Biol Chem; 2000 May; 275(18):13502-9. PubMed ID: 10788464
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage.
Jacques SL; Kuliopulos A
Biochem J; 2003 Dec; 376(Pt 3):733-40. PubMed ID: 13678420
[TBL] [Abstract][Full Text] [Related]
13. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.
Colognato R; Slupsky JR; Jendrach M; Burysek L; Syrovets T; Simmet T
Blood; 2003 Oct; 102(7):2645-52. PubMed ID: 12805069
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment.
Molino M; Woolkalis MJ; Reavey-Cantwell J; Praticó D; Andrade-Gordon P; Barnathan ES; Brass LF
J Biol Chem; 1997 Apr; 272(17):11133-41. PubMed ID: 9111010
[TBL] [Abstract][Full Text] [Related]
15. Mapping the interaction of bradykinin 1-5 with the exodomain of human protease activated receptor 4.
Nieman MT; Pagan-Ramos E; Warnock M; Krijanovski Y; Hasan AA; Schmaier AH
FEBS Lett; 2005 Jan; 579(1):25-9. PubMed ID: 15620686
[TBL] [Abstract][Full Text] [Related]
16. Selective tryptic cleavage at the tethered ligand site of the amino terminal domain of proteinase-activated receptor-2 in intact cells.
Al-Ani B; Hollenberg MD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1120-8. PubMed ID: 12604689
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling.
Mihara K; Ramachandran R; Saifeddine M; Hansen KK; Renaux B; Polley D; Gibson S; Vanderboor C; Hollenberg MD
Mol Pharmacol; 2016 May; 89(5):606-14. PubMed ID: 26957205
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells.
Greenberg DL; Mize GJ; Takayama TK
Biochemistry; 2003 Jan; 42(3):702-9. PubMed ID: 12534282
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptor-2 (PAR-2) in brain microvascular endothelium and its regulation by plasmin and elastase.
Dömötör E; Bartha K; Machovich R; Adam-Vizi V
J Neurochem; 2002 Mar; 80(5):746-54. PubMed ID: 11948237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
